Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank77
3Y CAGR+119.8%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+119.8%/yr
vs -58.2%/yr prior
Acceleration
+177.9pp
Accelerating
Percentile
P77
Within normal range
vs 3Y Ago
10.6x
Strong expansion
Streak
2 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$15.79M+2531.8%
2024$600000.00-
2023$0.00-100.0%
2022$1.49M-9.2%
2021$1.64M-
2020$0.00-100.0%
2019$89.60M+84.3%
2018$48.61M+86.7%
2017$26.04M+68.7%
2016$15.44M-